- Filed
- Mar 18, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 13, 2025 | 3.97M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 3.44M sh |
| Capex | FY 2024 · Dec 31, 2023 | $73.56K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$15.76M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $3.37M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $11.4M |
| Current Assets | FY 2024 · Dec 31, 2023 | $3.6M |
| Total Assets | FY 2024 · Dec 31, 2023 | $4.55M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$6.54 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$6.54 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $7.43M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $15.49M |
| Net Income | FY 2024 · Dec 31, 2023 | −$22.46M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$22.92M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | −$401.3K |